What is the recommended treatment for a 5‑month‑old infant with TSH 150 mIU/L, free T4 9.6 ng/dL, and free T3 4.1 pg/mL?

Immediate Levothyroxine Treatment Required

Start levothyroxine immediately at 10-15 mcg/kg/day (approximately 50-75 mcg daily for a 5-month-old) - this infant has severe congenital hypothyroidism with markedly elevated TSH of 150 mIU/L and requires urgent treatment to prevent permanent neurodevelopmental damage. 1

Critical Treatment Initiation

Your infant's laboratory values indicate severe primary hypothyroidism:

• TSH 150 mIU/L (severely elevated; normal <10 mIU/L after 2 weeks of age)
• Free T4 9.6 ng/dL (assuming units are ng/dL, this is low-normal to low depending on assay)
• Free T3 4.1 pg/mL (less relevant for diagnosis and management)

Starting Dose Strategy

Use the higher end of the dosing range (15 mcg/kg/day) given the severity indicated by the extremely elevated TSH. This severe presentation suggests either thyroid dysgenesis or dyshormonogenesis and warrants aggressive initial treatment to rapidly normalize thyroid hormone levels. 1

For a typical 5-month-old weighing 6-7 kg:

• Starting dose: 75-100 mcg daily
• Crush tablets and mix with small amount of water or breast milk
• Administer consistently - same time daily, either morning or evening
• Give at least 30 minutes away from soy, iron, calcium, or vitamin D supplements 1

Urgent Diagnostic Workup (Do Not Delay Treatment)

While initiating treatment immediately, arrange:

1. Physical examination for:

   • Congenital heart defects (particularly septal defects) - present in higher frequency with CH 1
   • Dysmorphic features
   • Umbilical hernia, macroglossia, hypotonia
   • Developmental assessment

2. Thyroid imaging (after treatment started):

   • Ultrasound and/or radionuclide scan to identify thyroid dysgenesis vs. dyshormonogenesis
   • Never delay treatment for imaging 1

3. Bone age assessment (knee X-ray):

   • Assess for absent femoral/tibial epiphyses indicating severe intrauterine hypothyroidism
   • This helps predict neurodevelopmental risk 1

Intensive Monitoring Protocol

First Month (Critical Period)

• Week 1-2: Check TSH and free T4

  • Goal: Rapidly raise T4 above 10 μg/dL (130 nmol/L)
  • TSH normalization takes longer; don't reduce dose based on single elevated T4 1

• Week 4: Repeat TSH and free T4

  • Continue every 2 weeks until TSH normalizes

Months 2-6

• Every 2 weeks until TSH completely normalized
• Then every 1-3 months through 12 months of age 1

Target Ranges During Treatment

• TSH: Age-specific reference range (avoid undetectable <0.05 mIU/L)
• Free T4: Upper half of age-specific reference range
• Blood samples must be drawn at least 4 hours after last levothyroxine dose 1

Critical Pitfalls to Avoid

1. Do NOT reduce dose based on single elevated T4 - TSH normalization lags behind T4 normalization 1

2. Avoid interference with absorption:

   • No soy formula/products within 2-3 hours of dose
   • Separate iron and calcium supplements by at least 4 hours
   • Exercise caution with vitamin D in first weeks (risk of hypercalcemia) 1

3. Do NOT switch between brand and generic formulations - use brand levothyroxine, especially in infancy, as bioequivalence is not guaranteed in severe cases 1

4. Ensure compliance - provide written instructions to parents about administration technique and importance of daily dosing 1

Neurodevelopmental Considerations

At 5 months, this infant has already experienced a critical period of thyroid hormone deficiency. The extremely high TSH suggests this is not a missed newborn screen but rather late diagnosis or non-compliance if previously diagnosed. 2

High-risk features present:

• Very high TSH at diagnosis (>150 mIU/L)
• Late age at treatment initiation (5 months vs. ideal <2 weeks)
• Likely very low initial T4 (though your reported value needs unit clarification)

These infants require:

• Developmental monitoring at every visit
• Early intervention services if delays identified
• Possible neuropsychological testing at school age
• Higher likelihood of subtle learning difficulties or ADHD even with treatment 1

Re-evaluation at Age 3 Years

If there's any possibility this could be transient hypothyroidism (unlikely given severity), consider re-evaluation at age 3 years by:

• Reducing levothyroxine dose by 30% for 2-3 weeks
• Recheck TSH - if rises to ≥10 mIU/L, confirms permanent CH
• Most cases with TSH >150 are permanent and require lifelong therapy 1, 3

The priority now is immediate treatment initiation and intensive monitoring to minimize further neurodevelopmental impact. 1, 4